Bank & Trust Company’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.58K Sell
823
-78
-9% -$166 ﹤0.01% 297
2026
Q1
$2.05K Hold
901
﹤0.01% 291
2025
Q4
$2.88K Sell
901
-1,757
-66% -$4.41K ﹤0.01% 279
2025
Q3
$6.67K Hold
2,658
﹤0.01% 238
2025
Q2
$8.82K Sell
2,658
-64
-2% -$228 0.01% 231
2025
Q1
$11.4K Hold
2,722
0.01% 222
2024
Q4
$13.1K Sell
2,722
-48
-2% -$225 0.01% 210
2024
Q3
$10.2K Sell
2,770
-1,381
-33% -$4.89K 0.01% 223
2024
Q2
$16.8K Buy
+4,151
New +$17.7K 0.01% 197

Other funds holding PETS

Bank & Trust Company's PETS Position: Q2 2026 in Review

Bank & Trust Company reduced its PetMed Express (PETS) stake by 8.7% in Q2 2026, selling an estimated $166 and leaving 823 shares worth $1.58K. The position accounts for ﹤0.01% of the portfolio, ranked #297.

Bank & Trust Company first reported a position in PETS in Q2 2024 and has held it in 9 quarters since. The position peaked at $16.8K in Q2 2024. 7 funds tracked by Wall St. Rank hold PETS as of Q2 2026.

  • Bank & Trust Company held 823 shares of PetMed Express worth $1.58K as of Q2 2026.
  • Bank & Trust Company sold 78 PetMed Express shares in Q2 2026, an estimated $166.
  • PetMed Express made up ﹤0.01% of Bank & Trust Company's portfolio in Q2 2026, its #297 holding.
  • Bank & Trust Company first reported a position in PetMed Express in Q2 2024 and has held it in 9 quarters since.
  • Bank & Trust Company's PetMed Express position peaked at $16.8K in Q2 2024.
  • 7 funds tracked by Wall St. Rank held PetMed Express as of Q2 2026.

Based on Bank & Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.